Akari Therapeutics PLC (AKTX) vs MARKER THERAPEUTICS, INC. (MRKR)

Akari Therapeutics PLC and MARKER THERAPEUTICS, INC. are both Biotechnology companies. MARKER THERAPEUTICS, INC. is the larger, with a market value of $19.8M against $17.6M — 1.1× the size. Across the 11 metrics below, Akari Therapeutics PLC leads on 6 and MARKER THERAPEUTICS, INC. on 5.

Valuation

Metric AKTX MRKR Biotechnology median
P/E n/m n/m 7.88
P/S n/m 4.67 11.47
P/B 0.94 1.83 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m n/m 0.74
EV/Sales n/m 2.33 10.73
Earnings yield (265.10%) (35.65%) (28.84%)
Free cash flow yield (61.74%) (98.59%) (23.03%)

Profitability

Metric AKTX MRKR Biotechnology median
Gross margin 0.00% 100.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (140.09%) (76.87%) (57.72%)
Return on assets (69.16%) (59.33%) (49.22%)
Return on invested capital (167.93%) (566.75%) 0.00%

Growth

Metric AKTX MRKR Biotechnology median
Revenue growth (TTM) — (27.83%) 5.64%
EPS growth (last fiscal year) 68.99% 33.61% —
Revenue growth, 5-year CAGR — 50.02% 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric AKTX MRKR Biotechnology median
Debt to equity 0.04 0.07 0.00
Current ratio 0.60 6.03 4.73
Net debt to EBITDA 0.27 1.32 0.96

Dividend

Metric AKTX MRKR Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric AKTX MRKR Biotechnology median
Market cap 17.61m 19.84m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack